These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16005948)

  • 1. Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose.
    Carrera MR; Trigo JM; Wirsching P; Roberts AJ; Janda KD
    Pharmacol Biochem Behav; 2005 Aug; 81(4):709-14. PubMed ID: 16005948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of a cocaine-binding antibody.
    Larsen NA; Zhou B; Heine A; Wirsching P; Janda KD; Wilson IA
    J Mol Biol; 2001 Aug; 311(1):9-15. PubMed ID: 11469854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality.
    Macêdo DS; Santos RS; Belchior LD; Neto MA; Vasconcelos SM; Lima VT; Fonteles MM; Viana GS; de Sousa FC
    Epilepsy Behav; 2004 Dec; 5(6):852-6. PubMed ID: 15582832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats.
    Byrnes-Blake KA; Laurenzana EM; Landes RD; Gentry WB; Owens SM
    Eur J Pharmacol; 2005 Oct; 521(1-3):86-94. PubMed ID: 16182279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of monoclonal antibodies directed against cocaine and cocaethylene: potential new tools for immunotherapy.
    Danger Y; Devys A; Gadjou C; Galons H; Blanchard D; Folléa G
    Hybrid Hybridomics; 2004 Aug; 23(4):212-8. PubMed ID: 15319068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice.
    Hoffman RS; Henry GC; Wax PM; Weisman RS; Howland MA; Goldfrank LR
    J Pharmacol Exp Ther; 1992 Nov; 263(2):698-702. PubMed ID: 1432697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely low frequency magnetic field effects on premorbid behaviors produced by cocaine in the mouse.
    Kim J; Baik KY; Lee BC; Kang SY; Shin SH; Soh KS
    Bioelectromagnetics; 2004 May; 25(4):245-50. PubMed ID: 15114633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine alters catalase activity in prefrontal cortex and striatum of mice.
    Macêdo DS; de Vasconcelos SM; dos Santos RS; Aguiar LM; Lima VT; Viana GS; de Sousa FC
    Neurosci Lett; 2005 Oct; 387(1):53-6. PubMed ID: 16085363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopharmacotherapeutic manifolds and modulation of cocaine overdose.
    Treweek JB; Roberts AJ; Janda KD
    Pharmacol Biochem Behav; 2011 May; 98(3):474-84. PubMed ID: 21356233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for the treatment of drug abuse.
    Kosten T; Owens SM
    Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antidote for acute cocaine toxicity.
    Treweek JB; Janda KD
    Mol Pharm; 2012 Apr; 9(4):969-78. PubMed ID: 22380623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticocaine catalytic antibodies.
    Deng SX; de Prada P; Landry DW
    J Immunol Methods; 2002 Nov; 269(1-2):299-310. PubMed ID: 12379369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalational model of cocaine exposure in mice: neuroteratological effects.
    He F; Lidow IA; Lidow MS
    Neurotoxicol Teratol; 2006; 28(2):181-97. PubMed ID: 16414242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies.
    Meijler MM; Kaufmann GF; Qi L; Mee JM; Coyle AR; Moss JA; Wirsching P; Matsushita M; Janda KD
    J Am Chem Soc; 2005 Mar; 127(8):2477-84. PubMed ID: 15725002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second-generation vaccine protects against the psychoactive effects of cocaine.
    Carrera MR; Ashley JA; Wirsching P; Koob GF; Janda KD
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1988-92. PubMed ID: 11172063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors.
    Witkin JM; Levant B; Zapata A; Kaminski R; Gasior M
    J Pharmacol Exp Ther; 2008 Sep; 326(3):930-8. PubMed ID: 18566292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol.
    Shah NG; Lathrop SL; Reichard RR; Landen MG
    Addiction; 2008 Jan; 103(1):126-36. PubMed ID: 18028518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is immunotherapy an opportunity for effective treatment of drug addiction?
    Zalewska-Kaszubska J
    Vaccine; 2015 Nov; 33(48):6545-51. PubMed ID: 26432911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human recombinant monoclonal antibody to cocaine: Preparation, characterization and behavioral studies.
    Eubanks LM; Ellis BA; Cai X; Schlosburg JE; Janda KD
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4664-4666. PubMed ID: 25205191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.
    Kuhar MJ; Carroll FI; Bharat N; Landry DW
    Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.